Mondell L. Beach

3.5k total citations · 1 hit paper
31 papers, 2.8k citations indexed

About

Mondell L. Beach is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, Mondell L. Beach has authored 31 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Medicine, 16 papers in Pharmacology and 12 papers in Epidemiology. Recurrent topics in Mondell L. Beach's work include Antibiotic Resistance in Bacteria (17 papers), Antibiotics Pharmacokinetics and Efficacy (16 papers) and Bacterial Identification and Susceptibility Testing (12 papers). Mondell L. Beach is often cited by papers focused on Antibiotic Resistance in Bacteria (17 papers), Antibiotics Pharmacokinetics and Efficacy (16 papers) and Bacterial Identification and Susceptibility Testing (12 papers). Mondell L. Beach collaborates with scholars based in United States, Brazil and Australia. Mondell L. Beach's co-authors include Michael A. Pfaller, Ronald N. Jones, Daniel J. Diekema, Jan Bell, Franz‐Josef Schmitz, Jorgelina Smayevsky, Hélio S. Sader, Gary V. Doern, Kari C. Kugler and Robert N. Jones and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Mondell L. Beach

31 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Survey of Infections Due toStaphylococcusSpecies: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999

2001 1.1k citations Daniel J. Diekema, Michael A. Pfaller et al. Clinical Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mondell L. Beach United States	21	1.3k	996	788	750	652	31	2.8k
John D. Rihs United States	27	1.2k 0.9×	805 0.8×	443 0.6×	1.3k 1.8×	483 0.7×	47	3.2k
Alicia Hidrón United States	14	1.9k 1.5×	1.0k 1.0×	1.2k 1.5×	1.2k 1.6×	809 1.2×	31	4.1k
Eui-Chong Kim South Korea	23	769 0.6×	762 0.8×	1.1k 1.4×	1.1k 1.4×	413 0.6×	61	2.8k
Bette Jensen United States	27	1.4k 1.1×	768 0.8×	578 0.7×	548 0.7×	770 1.2×	45	2.9k
Juan J. Picazo Spain	34	1.9k 1.4×	1.0k 1.0×	962 1.2×	1.7k 2.3×	541 0.8×	156	4.2k
Martín E. Stryjewski United States	35	2.9k 2.2×	1.4k 1.4×	526 0.7×	1.5k 2.0×	996 1.5×	80	4.6k
Manel Almela Spain	36	2.3k 1.7×	1.4k 1.4×	504 0.6×	2.3k 3.1×	391 0.6×	111	4.3k
Peter K. Linden United States	25	1.4k 1.1×	932 0.9×	615 0.8×	869 1.2×	462 0.7×	34	2.8k
Sandra Tallent United States	16	2.7k 2.0×	920 0.9×	489 0.6×	1.8k 2.4×	973 1.5×	42	4.5k
Vibeke Thamdrup Rosdahl Denmark	30	2.2k 1.7×	1.1k 1.1×	490 0.6×	837 1.1×	1.1k 1.7×	115	3.8k

Countries citing papers authored by Mondell L. Beach

Since Specialization

Citations

This map shows the geographic impact of Mondell L. Beach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mondell L. Beach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mondell L. Beach more than expected).

Fields of papers citing papers by Mondell L. Beach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mondell L. Beach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mondell L. Beach. The network helps show where Mondell L. Beach may publish in the future.

Co-authorship network of co-authors of Mondell L. Beach

This figure shows the co-authorship network connecting the top 25 collaborators of Mondell L. Beach. A scholar is included among the top collaborators of Mondell L. Beach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mondell L. Beach. Mondell L. Beach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jones, Ronald N., Douglas J. Biedenbach, & Mondell L. Beach. (2003). Influence of patient age on the susceptibility patterns of Streptococcus pneumoniae isolates in North America (2000-2001): report from the SENTRY Antimicrobial Surveillance Program. Diagnostic Microbiology and Infectious Disease. 46(1). 77–80. 31 indexed citations

Deshpande, Lalitagauri M., Mondell L. Beach, Alan H. Mutnick, & Ronald N. Jones. (2003). Antimicrobial activity of LB10827, a new orally administered cephalosporin, tested against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae. Clinical Microbiology and Infection. 9(8). 893–896. 1 indexed citations

Jones, Ronald N., Hélio S. Sader, & Mondell L. Beach. (2003). Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18 569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997–2001). International Journal of Antimicrobial Agents. 22(6). 551–556. 96 indexed citations

Gordon, Kelley A., Mondell L. Beach, Douglas J. Biedenbach, et al.. (2002). Antimicrobial susceptibility patterns of β-hemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997–2000). Diagnostic Microbiology and Infectious Disease. 43(2). 157–162. 54 indexed citations

Pfaller, Michael A., et al.. (2001). Comparative antimicrobial spectrum and activity of BMS284756 (T-3811, a desfluoroquinolone) tested against 656 Enterobacteriaceae, including preliminary in vitro susceptibility test comparisons and development. International Journal of Antimicrobial Agents. 18(2). 141–145. 10 indexed citations

Biedenbach, Douglas J., Mondell L. Beach, & Ronald N. Jones. (2001). In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum β-lactamases. Diagnostic Microbiology and Infectious Disease. 40(4). 173–177. 82 indexed citations

Jones, Ronald N., Mondell L. Beach, & Michael A. Pfaller. (2001). Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000): More alike than different!. Diagnostic Microbiology and Infectious Disease. 41(3). 161–163. 22 indexed citations

Diekema, Daniel J., Michael A. Pfaller, Franz‐Josef Schmitz, et al.. (2001). Survey of Infections Due toStaphylococcusSpecies: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clinical Infectious Diseases. 32(s2). S114–S132. 1090 indexed citations breakdown →

Jones, Ronald N., et al.. (2000). Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). Diagnostic Microbiology and Infectious Disease. 37(2). 115–125. 51 indexed citations

10.

Gales, Ana Cristina, Ronald N. Jones, Kelley A. Gordon, et al.. (2000). Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY Antimicrobial Surveillance Program (1998). Journal of Antimicrobial Chemotherapy. 45(3). 295–303. 139 indexed citations

11.

Diekema, Daniel J., Michael A. Pfaller, Ronald N. Jones, et al.. (2000). Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. International Journal of Antimicrobial Agents. 13(4). 257–271. 100 indexed citations

12.

Pfaller, Michael A., Ronald N. Jones, Gary V. Doern, et al.. (1999). Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY antimicrobial surveillance program. Diagnostic Microbiology and Infectious Disease. 33(4). 283–297. 199 indexed citations

13.

Doern, G V, et al.. (1999). Antimicrobial Activity of Gatifloxacin Tested Against 1676 Gram-Positive Cocci Resistant to Ciprofloxacin. Drugs. 58(Supplement 2). 162–163. 1 indexed citations

14.

Doern, Gary V., Ronald N. Jones, Michael A. Pfaller, Kari C. Kugler, & Mondell L. Beach. (1999). Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). Diagnostic Microbiology and Infectious Disease. 34(1). 65–72. 120 indexed citations

15.

Jones, Ronald N., Kari C. Kugler, M E Erwin, et al.. (1999). Gatifloxacin (AM-1155, CG 5501) susceptibility testing interpretive criteria and quality control guidelines for dilution and disk (5-μg) diffusion methods. Diagnostic Microbiology and Infectious Disease. 33(4). 247–253. 8 indexed citations

16.

Pfaller, Michael A., Robert N. Jones, & Mondell L. Beach. (1999). Survey of Bloodstream Infections Due to Gram-Negative Bacilli: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997. Clinical Infectious Diseases. 29(3). 595–607. 254 indexed citations

17.

Jones, Ronald N., David M. Johnson, M E Erwin, et al.. (1999). Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validation. Diagnostic Microbiology and Infectious Disease. 34(2). 91–98. 15 indexed citations

18.

Biedenbach, Douglas J., Mondell L. Beach, & Ronald N. Jones. (1998). Antimicrobial activity of gatifloxacin tested against Neisseria gonorrhoeae using three methods and a collection of fluoroquinolone-resistant strains. Diagnostic Microbiology and Infectious Disease. 32(4). 307–311. 15 indexed citations

19.

Beach, Mondell L., et al.. (1994). Consequences of intravascular catheter sepsis. American Journal of Infection Control. 22(4). 242–243. 4 indexed citations

20.

Arnow, Paul M., et al.. (1993). Consequences of Intravascular Catheter Sepsis. Clinical Infectious Diseases. 16(6). 778–784. 224 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact